Literature DB >> 22415346

Hypertension resulting from overexpression of translationally controlled tumor protein increases the severity of atherosclerosis in apolipoprotein E knock-out mice.

Yujeong Cho1, Jeehye Maeng, Jungmin Ryu, Hyekyoung Shin, Miyoung Kim, Goo Taeg Oh, Moo-Yeol Lee, Kyunglim Lee.   

Abstract

Hypertension is a well-established etiological factor for atherogenesis. We previously showed that transgenic mice overexpressing translationally controlled tumor protein (TCTP) develop systemic arterial hypertension. In this study we explored the cardiovascular effects of TCTP overexpression and possibly of the resultant hypertension on the severity of atherosclerosis in apolipoprotein E-deficient mice. Through multiple mating of TCTP-overexpressing transgenic mice (TCTP-TG) with apolipoprotein E knock-out mice (ApoE KO), we generated non-transgenic (nTG), TCTP-TG, nTG/ApoE KO and TCTP-TG/ApoE KO mice with similar genetic background. Male mice, 7-week old, were fed a lipid-enriched Western diet for 16 weeks, and blood pressure and body weight change were monitored every 2 weeks. Plasma lipid profiles and atherosclerotic lesions in aorta were quantified at the end of study. We found that blood pressure levels of TCTP-TG and TCTP-TG/ApoE KO, were similarly elevated while nTG and nTG/ApoE KO mice were normotensive. TCTP overexpression in ApoE KO mice led to significant exacerbation of atherosclerotic lesions. Feeding Western diet resulted in increases in total cholesterol, triglyceride (TG) and low density lipoprotein, and decreased high density lipoprotein (HDL) in ApoE KO mice. No significant differences were found in plasma lipid profiles of nTG/ApoE KO and TCTP-TG/ApoE KO. This study suggests that overexpression of TCTP, which induces hypertension, also accelerates the development of atherosclerotic lesion caused by high-fat and high-cholesterol diet without significantly altering plasma lipid profiles. We conclude that TCTP-induced hypertension could increase the severity of atherosclerotic lesion and suggest that inhibition of TCTP or its signaling pathways may be a potential approach to the therapy of both diseases, hypertension and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415346     DOI: 10.1007/s11248-012-9609-z

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  21 in total

Review 1.  The antioxidant properties of serum albumin.

Authors:  Marjolaine Roche; Philippe Rondeau; Nihar Ranjan Singh; Evelyne Tarnus; Emmanuel Bourdon
Journal:  FEBS Lett       Date:  2008-05-12       Impact factor: 4.124

Review 2.  Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial.

Authors:  John B Standridge
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Certain aspects of protein metabolism in hypercholesteremic chickens.

Authors:  S Banerjee; P N Rao
Journal:  Proc Soc Exp Biol Med       Date:  1966-01

4.  The effect of endothelin-1 on Src-family tyrosine kinases and Na,K-ATPase activity in porcine lens epithelium.

Authors:  A Mandal; M Shahidullah; C Beimgraben; N A Delamere
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

5.  Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.

Authors:  Valdeci da Cunha; Doris M Tham; Baby Martin-McNulty; Gary Deng; Jerrick J Ho; Dennis W Wilson; John C Rutledge; Ronald Vergona; Mark E Sullivan; Yi-Xin Jim Wang
Journal:  Atherosclerosis       Date:  2005-01       Impact factor: 5.162

6.  Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.

Authors:  Daiana Weiss; W Robert Taylor
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

7.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

8.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162

9.  Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond.

Authors:  Avani A Pendse; Jose M Arbones-Mainar; Lance A Johnson; Michael K Altenburg; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  6 in total

Review 1.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

2.  Fortilin reduces apoptosis in macrophages and promotes atherosclerosis.

Authors:  Decha Pinkaew; Rachel J Le; Yanjie Chen; Mahmoud Eltorky; Ba-Bie Teng; Ken Fujise
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

Review 3.  Dysregulation of TCTP in Biological Processes and Diseases.

Authors:  Ulrich-Axel Bommer; Adam Telerman
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

4.  High Plasma Levels of Fortilin in Patients with Coronary Artery Disease.

Authors:  Masayuki Aoyama; Yoshimi Kishimoto; Emi Saita; Reiko Ohmori; Kojiro Tanimoto; Masato Nakamura; Kazuo Kondo; Yukihiko Momiyama
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

5.  Up-regulation of Rhoa/Rho kinase pathway by translationally controlled tumor protein in vascular smooth muscle cells.

Authors:  Jeehye Maeng; Vadim Sheverdin; Hyekyoung Shin; Insu Ha; Sun Sik Bae; Hsin-Fang Yang-Yen; Kyunglim Lee
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

Review 6.  Some Biological Consequences of the Inhibition of Na,K-ATPase by Translationally Controlled Tumor Protein (TCTP).

Authors:  Jiwon Jung; Seonhyung Ryu; In A Ki; Hyun Ae Woo; Kyunglim Lee
Journal:  Int J Mol Sci       Date:  2018-06-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.